Is a complete INBS research report available?

No complete published report is available for Intelligent Bio Solutions Inc. (INBS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Intelligent Bio Solutions Inc. (INBS)

NASDAQ: INBS · USD

$1.58

+0.02 (+1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INBS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.8M
Revenue (ttm)	3.9M
Net income (ttm)	-11.6M
EPS (ttm)	-$11.4
Shares out	2.4M
Volume	18,425
Beta	4.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.9M
Net income (ttm): -11.6M
EPS (ttm): -$11.4
Market cap: 3.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INBS indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001725430
Company name	Intelligent Bio Solutions Inc.
Country	United States
Country code	US
Cusip	36151G709
Employees	55
Employees Change	5%
Employees Change Percent	10
Enterprise value	$-1.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
Isin	US36151G7097
Last refreshed	2026-07-31
Market cap	$3.8M
Market cap category	Nano-Cap
Price	$1.58
Price currency	USD
Rev Per Employee	71,150.13x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	3841
Symbol	INBS
Website	https://ibs.inc

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-308.28%
FCF yield	-299.67%
P/B ratio	0.35x
P/S ratio	0.96x
PS Forward	0.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-297.81%
EBITDA Margin	-269.2%
Gross margin	47.25%
Gross Profit	$1.8M
Gross Profit Growth	7.07%
Gross Profit Growth Q	56.83%
Gross Profit Growth3 Y	88.26%
Gross Profit Growth5 Y	33.15%
Net Income	$-11.6M
Net Income Growth Years	0%
Pretax Margin	-297.8%
Profit Margin	-296.77%
Profit Per Employee	$-211,153
ROA	-57.25
Roa5y	-43.22
ROCE	-113.7
ROE	-170.2
Roe5y	-158.9
ROIC	-87.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-90.11%
Cagr3y	-81.18%
Cagr5y	-81.84%
EPS Growth Quarters	3
EPS Growth Years	4
Revenue Growth	33.26x
Revenue Growth Q	45.54x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	68.79x
Revenue Growth5 Y	54.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.32
Assets	$14.9M
Cash	$6.9M
Current Assets	$9.7M
Current Liabilities	$4.6M
Debt	$1.8M
Debt Equity	$0.21
Equity	$8.8M
Interest Coverage	-246.4
Liabilities	$6.1M
Long Term Assets	$5.1M
Long Term Liabilities	$1.5M
Net Cash	$5M
Net Cash By Market Cap	$133
Net Cash Growth	118.38%
Net Debt Equity	$-0.57
Tangible Book Value	$6M
Tangible Book Value Per Share	$2.98
WACC	18.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.11
Inventory Turnover	3.22
Net Working Capital	$-1.3M
Quick ratio	1.8
Working Capital	$5.1M
Working Capital Turnover	$1.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-138.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-90.09%
200-day SMA	5.29
3Y total return	-99.33%
50-day SMA	2.26
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.98%
All Time High	34,175.8
All Time High Change	-100%
All Time High Date	2020-12-23
All Time Low	1.52
All Time Low Change	3.62%
All Time Low Date	2026-07-28
ATR	0.17
Beta	4.17
Beta1y	1.78
Beta2y	1.39
Ch YTD	-83.47
High	1.59
High52	24.9
High52 Date	2026-01-12
High52ch	-93.67%
Low	1.54
Low52	1.52
Low52 Date	2026-07-28
Low52ch	3.62%
Ma50ch	-30.37%
Premarket Change Percent	0.65
Premarket Price	$1.56
Premarket Volume	568
Price vs 200-day SMA	-70.25%
RSI	25.04
RSI Monthly	21.95
RSI Weekly	35.66
Sharpe ratio	-0.71x
Sortino ratio	-1.53
Total Return	-138.67%
Tr YTD	-83.47
Tr1m	-29.05%
Tr1w	-12.98%
Tr3m	-32.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1.58
Earnings Revenue Estimate	1,220,000x
Earnings Revenue Estimate Growth	44.57x
Operating Income	$-11.2M
Operating margin	-286.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,171,377%
Float Percent	90.78%
Shares Insiders	3.78%
Shares Institutions	4.54%
Shares Out	2,391,846
Shares Qo Q	67.7%
Shares Yo Y	138.67%
Short Float	4.76%
Short Ratio	2.03
Short Shares	4.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.4M
Adjusted OCF	-11,064,650
Average Volume	83,802.35x
Bv Per Share	4.48
CAPEX	$-334,248
Ch1m	-29.05
Ch1w	-12.98
Ch1y	-90.09
Ch3m	-32.84
Ch3y	-99.33
Ch5y	-99.98
Ch6m	-82.5
Change	1.61%
Change From Open	1.61
Close	1.55
Days Gap	0
Depreciation Amortization	963,604
Dollar Volume	29,019.4
Earnings Date	2026-09-04
Earnings Time	bmo
EBIT	$-11.7M
EBITDA	$-10.5M
EPS	$-11.36
F Score	3
FCF	$-11.3M
FCF EV Yield	905.58x
FCF Per Share	$-4.72
Financing CF	15,273,714
Fiscal Year End	June
Founded	2,016
Investing CF	-294,090
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2025-12-16
Last Split Type	Reverse
Last10k Filing Date	2025-08-15
Ma150	4.4
Ma150ch	-64.18%
Ma20	2
Ma20ch	-21.29%
Net CF	4,055,092
Next Earnings Date	2026-08-14
Open	1.55
Optionable	No
Position In Range	64.81
Post Close	1.58
Postmarket Change Percent	-2.15
Postmarket Price	$1.54
Ppne	2,113,898
Pre Close	1.55
Price Date	2026-07-30
Ptbv Ratio	0.63
Relative Volume	0.22x
Revenue	3,913,257x
SBC By Revenue	2.81x
Share Based Comp	109,779
Tr6m	-82.5%
Us State	New York
Volume	18,425
Z Score	-7.53

Intelligent Bio Solutions Inc. (INBS)

Coverage state: Market snapshot only — no published research

Generate the first INBS analysis

Price

Financial snapshot

Fair-value bridge

Latest news · INBS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INBS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INBS

Frequently asked questions